EZH2 and cancer: Despite interest in phosphorylation as an important non canonical oncogenic mechanism of EZH2 in cancer and the relevance of p38 MAPK in promoting breast cancer metastasis and as a therapeutic target13, whether p38 phosphorylates EZH2 in breast cancer has not yet been considered.